OZON - AGEN LYG and ARVL among pre market gainers

Calliditas Therapeutics (NASDAQ:CALT) +38% on FDA approval for kidney disease therapy. Kaixin Auto (NASDAQ:KXIN) +27% on a partnership agreement with Bujia for 10k new energy trucks. Biomerica (NASDAQ:BMRA) +18% preliminary second quarter revenue increase of approximately 238%, to approximately $4.6M. Mechel PAO (NYSE:MTL) +15%. FREYR Battery (NYSE:FREY) +14% secures 31 GWh inaugural offtake agreement with global ESS provider. American Virtual Cloud Technologies (NASDAQ:AVCT) +12% Kandy expands full PSTN replacement services to 40 countries. Doma Holdings (NYSE:DOMA) +11%. Canoo (NASDAQ:GOEV) +10% raises production guidance and U.S. facilities targets. Petros Pharmaceuticals (NASDAQ:PTPI) +10%. Accenture (NYSE:ACN) +10% on FQ1 results. Mesoblast (NASDAQ:MESO) +9% FDA’s OTAT in agreement pain reduction as primary endpoint in Mesoblast's Phase 3 program. MoneyLion (NYSE:ML) +8% agrees to acquire Even Financial for $440M, sees accretion. Ozon Holdings (NASDAQ:OZON) +7%. Vir Biotechnology (NASDAQ:VIR) +7%. Atai Life Sciences (NASDAQ:ATAI) +7% establishes the atai fellowship fund in psychedelic neuroscience with Massachusetts General Hospital’s center for the neuroscience of psychedelics. Navios Maritime (NYSE:NM) +7% on Q3 results. BriaCell

For further details see:

AGEN, LYG and ARVL among pre market gainers